Obtenez 3 mois à 0,99 $/mois + 20 $ de crédit Audible

OFFRE D'UNE DURÉE LIMITÉE
Page de couverture de The 'Dispatched' Podcast

The 'Dispatched' Podcast

The 'Dispatched' Podcast

Auteur(s): Daily Dispatch
Écouter gratuitement

À propos de cet audio

BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.

© 2025 The 'Dispatched' Podcast Politique
Épisodes
  • The 'Dispatched' Week in Review' - 7 November

    The 'Dispatched' Week in Review' - 7 November
    Nov 7 2025
    57 min
  • The 'Dispatched' Week in Review - 31 October

    The 'Dispatched' Week in Review - 31 October
    Oct 31 2025

    Reform efforts can struggle because they focus on health systems at their strongest point rather than their weakest. Framing is a pernicious tool used to justify delays and denials. We argue that the uptake of GLP-1 therapies in the US is delivering remarkable results, and that we need to apply the lessons from that experience in Australia, challenging institutional narratives and reframing the public debate to focus on public health benefits.
    Voir plus Voir moins
    46 min
  • The 'Dispatched' Week in Review'- 17 October

    The 'Dispatched' Week in Review'- 17 October
    Oct 17 2025

    We discuss what could be a significant policy shift in PBS decision-making, with clinical judgement backed by what is a 'common sense' outcome. It could be a new precedent, but only if all stakeholders demand clarity on the criteria so that it can be applied more broadly. We also reflect on patient advocacy in New Zealand, where access has become a political issue and the focus of a significant discussion at this week's Valuing Life Summit in Wellington.
    Voir plus Voir moins
    39 min
Pas encore de commentaire